113 related articles for article (PubMed ID: 16387360)
1. Development of a mantle cell lymphoma in an ATM heterozygous woman after occupational exposure to ionising radiation and somatic mutation of the second allele.
Briani C; Schlotter M; Lichter P; Kalla C
Leuk Res; 2006 Sep; 30(9):1193-6. PubMed ID: 16387360
[TBL] [Abstract][Full Text] [Related]
2. Mantle cell lymphoma is characterized by inactivation of the ATM gene.
Schaffner C; Idler I; Stilgenbauer S; Döhner H; Lichter P
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2773-8. PubMed ID: 10706620
[TBL] [Abstract][Full Text] [Related]
3. Atm heterozygosity does not increase tumor susceptibility to ionizing radiation alone or in a p53 heterozygous background.
Mao JH; Wu D; DelRosario R; Castellanos A; Balmain A; Perez-Losada J
Oncogene; 2008 Nov; 27(51):6596-600. PubMed ID: 18679420
[TBL] [Abstract][Full Text] [Related]
4. Peripheral blood complete remission after splenic irradiation in mantle-cell lymphoma with 11q22-23 deletion and ATM inactivation.
Filippi AR; Franco P; Galliano M; Ricardi U
Radiat Oncol; 2006 Sep; 1():35. PubMed ID: 16956411
[TBL] [Abstract][Full Text] [Related]
5. Atm heterozygous deficiency enhances development of mammary carcinomas in p53 heterozygous knockout mice.
Umesako S; Fujisawa K; Iiga S; Mori N; Takahashi M; Hong DP; Song CW; Haga S; Imai S; Niwa O; Okumoto M
Breast Cancer Res; 2005; 7(1):R164-70. PubMed ID: 15642165
[TBL] [Abstract][Full Text] [Related]
6. ATM germline mutations in women with familial breast cancer and a relative with haematological malignancy.
Paglia LL; Laugé A; Weber J; Champ J; Cavaciuti E; Russo A; Viovy JL; Stoppa-Lyonnet D
Breast Cancer Res Treat; 2010 Jan; 119(2):443-52. PubMed ID: 19404735
[TBL] [Abstract][Full Text] [Related]
7. Contribution of mutations in ATM to breast cancer development in the Czech population.
Soukupova J; Dundr P; Kleibl Z; Pohlreich P
Oncol Rep; 2008 Jun; 19(6):1505-10. PubMed ID: 18497957
[TBL] [Abstract][Full Text] [Related]
8. Atm haploinsufficiency does not affect ionizing radiation mutagenesis in solid mouse tissues.
Connolly L; Lasarev M; Jordan R; Schwartz JL; Turker MS
Radiat Res; 2006 Jul; 166(1 Pt 1):39-46. PubMed ID: 16808618
[TBL] [Abstract][Full Text] [Related]
9. [Adjuvant irradiation in breast cancer patients with ATM gene heterozygous mutations: special focus on clinical efficacy/toxicity].
Chargari C; Kirova YM; Even C; Monnier L; Dendale R; Campana F; Fourquet A
Cancer Radiother; 2009 Jun; 13(3):164-72. PubMed ID: 19162519
[TBL] [Abstract][Full Text] [Related]
10. ATM and breast cancer susceptibility.
Ahmed M; Rahman N
Oncogene; 2006 Sep; 25(43):5906-11. PubMed ID: 16998505
[TBL] [Abstract][Full Text] [Related]
11. Pathogenic ATM mutations occur rarely in a subset of multiple myeloma patients.
Austen B; Barone G; Reiman A; Byrd PJ; Baker C; Starczynski J; Nobbs MC; Murphy RP; Enright H; Chaila E; Quinn J; Stankovic T; Pratt G; Taylor AM
Br J Haematol; 2008 Sep; 142(6):925-33. PubMed ID: 18573109
[TBL] [Abstract][Full Text] [Related]
12. ATM gene mutations in former uranium miners of SDAG Wismut: a pilot study.
Schneider J; Philipp M; Yamini P; Dörk T; Woitowitz HJ
Oncol Rep; 2007 Feb; 17(2):477-82. PubMed ID: 17203191
[TBL] [Abstract][Full Text] [Related]
13. Effect of ATM heterozygosity on heritable DNA damage in mice following paternal F0 germline irradiation.
Baulch JE; Li MW; Raabe OG
Mutat Res; 2007 Mar; 616(1-2):34-45. PubMed ID: 17161850
[TBL] [Abstract][Full Text] [Related]
14. Absence of ATM hypermethylation in mantle cell and follicular lymphoma.
Chim CS; Wong KY; Loong F; Srivastava G
Leukemia; 2005 May; 19(5):880-2. PubMed ID: 15744354
[No Abstract] [Full Text] [Related]
15. Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma.
Akulevich NM; Saenko VA; Rogounovitch TI; Drozd VM; Lushnikov EF; Ivanov VK; Mitsutake N; Kominami R; Yamashita S
Endocr Relat Cancer; 2009 Jun; 16(2):491-503. PubMed ID: 19286843
[TBL] [Abstract][Full Text] [Related]
16. ATM mutations in sporadic lymphoid tumours.
Stankovic T; Stewart GS; Byrd P; Fegan C; Moss PA; Taylor AM
Leuk Lymphoma; 2002 Aug; 43(8):1563-71. PubMed ID: 12400598
[TBL] [Abstract][Full Text] [Related]
17. Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer.
Spring K; Ahangari F; Scott SP; Waring P; Purdie DM; Chen PC; Hourigan K; Ramsay J; McKinnon PJ; Swift M; Lavin MF
Nat Genet; 2002 Sep; 32(1):185-90. PubMed ID: 12195425
[TBL] [Abstract][Full Text] [Related]
18. Persistence of unrepaired DNA double strand breaks caused by inhibition of ATM does not lead to radio-sensitisation in the absence of NF-κB activation.
Veuger SJ; Durkacz BW
DNA Repair (Amst); 2011 Feb; 10(2):235-44. PubMed ID: 21144805
[TBL] [Abstract][Full Text] [Related]
19. ATM gene and lymphoid malignancies.
Gumy-Pause F; Wacker P; Sappino AP
Leukemia; 2004 Feb; 18(2):238-42. PubMed ID: 14628072
[TBL] [Abstract][Full Text] [Related]
20. Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma.
Greiner TC; Dasgupta C; Ho VV; Weisenburger DD; Smith LM; Lynch JC; Vose JM; Fu K; Armitage JO; Braziel RM; Campo E; Delabie J; Gascoyne RD; Jaffe ES; Muller-Hermelink HK; Ott G; Rosenwald A; Staudt LM; Im MY; Karaman MW; Pike BL; Chan WC; Hacia JG
Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2352-7. PubMed ID: 16461462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]